Tenaya Therapeutics, Inc. (TNYA)

NCM – Real vaqt narxi. Valyuta: USD

0.78

+0.03 (3.74%)

Bozor ochiq: Aug 12, 2026, 1:15 PM EDT

0.76

+0.00 (0.63%)

Oldingi bozordan keyin: Aug 11, 2026, 7:57 PM EDT

05.08.2026

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Positive Interim Data Shared in 2Q 2026 from the MyPEAK™-1 and RIDGE™-1 Clinical Trials Each Demonstrated Meaningful Improvements in Key Disease Characteristics Additional Data Releases Plus Updates on Regulatory Discussions on Pivotal Trial Plans for TN-201 and TN-401 Anticipated in 4Q 2026 TN-301 Advancing toward Phase 2 Trial Start in 2H 2027 $10 million Upfront Payment Received from Alnylam Collaboration Extends Cash Runway Through Q3 2027 SOUTH SAN FRANCISCO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update.

04.08.2026

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that members of management will host 1x1 meetings with investors at the upcoming Canaccord Genuity 46th Annual Growth Conference taking place from August 11-12, 2026 in Boston, Massachusetts.

Videolar

No Data

There is no data to display

Press-relizlar

05.08.2026

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

04.08.2026

Tenaya Therapeutics, Inc. (TNYA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Tenaya Therapeutics, Inc. (TNYA)

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Videolar

No Data

Press-relizlar

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Videolar

No Data

Press-relizlar

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Search stocks

Tenaya Therapeutics, Inc. (TNYA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Tenaya Therapeutics, Inc. (TNYA)

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Videolar

No Data

Press-relizlar

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

Videolar

No Data

Press-relizlar

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference